These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 8738729

  • 1. Propranolol plus molsidomine vs propranolol alone in the treatment of portal hypertension in patients with cirrhosis.
    García-Pagán JC, Escorsell A, Feu F, Bandi JC, Moitinho E, Casado M, Bosch J, Rodés J.
    J Hepatol; 1996 Apr; 24(4):430-5. PubMed ID: 8738729
    [Abstract] [Full Text] [Related]

  • 2. Effects of molsidomine, a long acting venous dilator, on portal hypertension. A hemodynamic study in patients with cirrhosis.
    Ruiz del Arbol L, García-Pagán JC, Feu F, Pizcueta MP, Bosch J, Rodés J.
    J Hepatol; 1991 Sep; 13(2):179-86. PubMed ID: 1744422
    [Abstract] [Full Text] [Related]

  • 3. Propranolol compared with propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis. A randomized controlled study.
    García-Pagán JC, Feu F, Bosch J, Rodés J.
    Ann Intern Med; 1991 May 15; 114(10):869-73. PubMed ID: 2014947
    [Abstract] [Full Text] [Related]

  • 4. Haemodynamic effects of combined treatment with molsidomine and propranolol on portal hypertension in conscious and unrestrained cirrhotic rats.
    Hori N, Okanoue T, Sawa Y, Mori T, Kashima K.
    J Gastroenterol Hepatol; 1996 Oct 15; 11(10):985-92. PubMed ID: 8912139
    [Abstract] [Full Text] [Related]

  • 5. Haemodynamic effects of molsidomine and propranolol in patients with cirrhosis.
    Combis JM, Vinel JP, Badia P, Barange K, Payen JL, Combis F, Desmorat H, Pascal JP.
    Br J Clin Pharmacol; 1996 May 15; 41(5):409-13. PubMed ID: 8735682
    [Abstract] [Full Text] [Related]

  • 6. [The effect of molsidomine on portal and cardiac hemodynamics in liver cirrhosis].
    Hüppe D, Jäger D, Tromm A, Tunn S, Barmeyer J, May B.
    Dtsch Med Wochenschr; 1991 May 31; 116(22):841-5. PubMed ID: 2036943
    [Abstract] [Full Text] [Related]

  • 7. Hemodynamic evaluation of molsidomine: a vasodilator with antianginal properties in patients with alcoholic cirrhosis.
    Vinel JP, Monnin JL, Combis JM, Calés P, Desmorat H, Pascal JP.
    Hepatology; 1990 Feb 31; 11(2):239-42. PubMed ID: 2307402
    [Abstract] [Full Text] [Related]

  • 8. Reduction of variceal pressure by propranolol: comparison of the effects on portal pressure and azygos blood flow in patients with cirrhosis.
    Feu F, Bordas JM, Luca A, García-Pagán JC, Escorsell A, Bosch J, Rodés J.
    Hepatology; 1993 Nov 31; 18(5):1082-9. PubMed ID: 8225212
    [Abstract] [Full Text] [Related]

  • 9. Pharmacologic prevention of variceal bleeding and rebleeding.
    Baiges A, Hernández-Gea V, Bosch J.
    Hepatol Int; 2018 Feb 31; 12(Suppl 1):68-80. PubMed ID: 29210030
    [Abstract] [Full Text] [Related]

  • 10. Propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis: long-term hemodynamic and renal effects.
    Morillas RM, Planas R, Cabré E, Galán A, Quer JC, Feu F, García Pagán JC, Bosch J, Gassull MA.
    Hepatology; 1994 Dec 31; 20(6):1502-8. PubMed ID: 7982651
    [Abstract] [Full Text] [Related]

  • 11. Hemodynamic effect of spironolactone in liver cirrhosis and propranolol-resistant portal hypertension.
    Sen S, De BK, Biswas PK, Biswas J, Das D, Maity AK.
    Indian J Gastroenterol; 2002 Dec 31; 21(4):145-8. PubMed ID: 12385542
    [Abstract] [Full Text] [Related]

  • 12. A randomized study of losartan vs propranolol: Effects on hepatic and systemic hemodynamics in cirrhotic patients.
    Castaño G, Viudez P, Riccitelli M, Sookoian S.
    Ann Hepatol; 2003 Dec 31; 2(1):36-40. PubMed ID: 15094704
    [Abstract] [Full Text] [Related]

  • 13. Hemodynamic effects of a combination of prazosin and terlipressin in patients with viral cirrhosis.
    Lee WC, Lin HC, Yang YY, Hou MC, Lee FY, Chang FY, Lee SD.
    Am J Gastroenterol; 2001 Apr 31; 96(4):1210-6. PubMed ID: 11316172
    [Abstract] [Full Text] [Related]

  • 14. Effects of isosorbide-5-mononitrate on variceal pressure and systemic and splanchnic haemodynamics in patients with cirrhosis.
    Escorsell A, Feu F, Bordas JM, García-Pagán JC, Luca A, Bosch J, Rodés J.
    J Hepatol; 1996 Apr 31; 24(4):423-9. PubMed ID: 8738728
    [Abstract] [Full Text] [Related]

  • 15. Effects of vasopressin and nicardipine on hemodynamics and liver function in patients with cirrhosis: comparison with vasopressin alone.
    Iwao T, Toyonaga A, Ikegami M, Oho K, Sumino M, Sakaki M, Shigemori H, Nakayama M, Sasaki E, Tanikawa K.
    J Hepatol; 1993 Nov 31; 19(3):345-52. PubMed ID: 8151095
    [Abstract] [Full Text] [Related]

  • 16. Continuous prazosin administration in cirrhotic patients: effects on portal hemodynamics and on liver and renal function.
    Albillos A, Lledó JL, Rossi I, Pérez-Páramo M, Tabuenca MJ, Bañares R, Iborra J, Garrido A, Escartín P, Bosch J.
    Gastroenterology; 1995 Oct 31; 109(4):1257-65. PubMed ID: 7557093
    [Abstract] [Full Text] [Related]

  • 17. Effects of alpha-adrenergic stimulation and beta-adrenergic blockade on azygos blood flow and splanchnic haemodynamics in patients with cirrhosis.
    Mastai R, Bosch J, Navasa M, Kravetz D, Bruix J, Viola C, Rodés J.
    J Hepatol; 1987 Feb 31; 4(1):71-9. PubMed ID: 3033061
    [Abstract] [Full Text] [Related]

  • 18. Combination of ketanserin and verapamil or propranolol in patients with alcoholic cirrhosis: search for an additive effect.
    Hadengue A, Moreau R, Cerini R, Koshy A, Lee SS, Lebrec D.
    Hepatology; 1989 Jan 31; 9(1):83-7. PubMed ID: 2908872
    [Abstract] [Full Text] [Related]

  • 19. Reduction of portal pressure by isosorbide-5-mononitrate in patients with cirrhosis. Effects on splanchnic and systemic hemodynamics and liver function.
    Navasa M, Chesta J, Bosch J, Rodés J.
    Gastroenterology; 1989 Apr 31; 96(4):1110-8. PubMed ID: 2925055
    [Abstract] [Full Text] [Related]

  • 20. Long-term haemodynamic effects of a 4-week regimen of nipradilol, a new beta-blocker with nitrovasodilating properties, in patients with portal hypertension due to cirrhosis. A comparative study with propranolol.
    Aramaki T, Sekiyama T, Katsuta Y, Kurokawa H, Komeichi H, Tsutsui H, Terada H, Ohsuga M, Satomura K, Okumura H.
    J Hepatol; 1992 May 31; 15(1-2):48-53. PubMed ID: 1354676
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.